Volume 81, Issue 10, Pages (October 2010)

Slides:

Advertisements

Similar presentations

August 30, 2009 at CET. Ticagrelor compared with clopidogrel in patients with acute coronary syndromes – the PLATO trial.

Advertisements

Unstable angina and NSTEMI

Canadian Diabetes Association Clinical Practice Guidelines Acute Coronary Syndromes and Diabetes Chapter 26 Jean-Claude Tardif, Phillipe L. L’Allier, David.

Current and Future Perspectives on Acute Coronary Syndromes Paul W. Armstrong MD AMI Quebec Montreal October 1, 2010.

ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.

DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.

Objective:To assess the effect of various clopidogrel and aspirin regimens on major CV events and ST in ACS patients undergoing PCI. Study:Multicenter,

Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.

MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

Support for implementing NICE guidance: Unstable angina and NSTEMI Unstable angina and NSTEMI, CG94, rd Edition March 2014.

Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC Guideline for the Management of Patients.

Cardiac causes of cardiac arrest

In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Prevalence,

Volume 119, Pages (October 2017)

Volume 63, Issue 1, Pages (July 2015)

Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy Jean-François Tanguay, MD, CSPQ, FRCPC, FACC,

Ischemic Heart Disease

Guidelines for the Management of Patients With ST- Elevation Myocardial Infarction Adapted from Focused Updates: ACC/AHA 2009.

Copyright © 2005 American Medical Association. All rights reserved.

Antiplatelet therapy for STEMI

Proposed use of P2Y12 inhibitors

Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE.

Ischaemic Heart Disease Acute Coronary Syndrome

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.

Abela M, Lentini F, Gatt A, Felice Malta Medial School Conference 2012

Contemporary Diagnosis and Management of Unstable Angina

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Glenn N. Levine et al. JACC 2016;68:

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial

Section A: Introduction

European Heart Association Journal 2007 April

Sudden Cardiac Death From the Perspective of Coronary Artery Disease

Eugene Braunwald, MD, Marc S. Sabatine, MD, MPH

Recent Temporal Trends in the Presentation, Management, and Outcome of Women Hospitalized with Acute Coronary Syndromes Avi Sabbag, MD, Shlomi Matetzky,

Figure 2 Ischaemic and bleeding outcomes in the major clinical trials

Cost-Effectiveness of Introducing Point-of-Care Test for Detection of Level of Glycogen Phosphorylase in Early Diagnostic Algorithm of Acute Coronary.

Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy Jean-François Tanguay, MD, CSPQ, FRCPC, FACC,

Temporary Is Not Always Benign: Similarities and Differences Between Transient Ischemic Attack and Angina Antonio Carolei, MD, Francesca Pistoia, MD,

Kay Lee Park, MD, Robert J. Goldberg, PhD, Frederick A

Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction P.-G. Chassot, A. Delabays, D.R. Spahn

Attributable Cost and Length of Stay for Patients with Enoxaparin-Associated Bleeding Surasak Saokaew, PharmD, Narinee Khaisombat, MSc, Nathorn Chaiyakunapruk,

The incidence and outcomes of acute coronary syndromes in a central European country: Results of the CZECH-2 registry Petr Tousek, Frantisek Tousek,

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Flow chart of the study population according to thienopyridines used in the FAST-MI registry in patients with STEMI and NSTEMI. FAST-MI, French Registry.

Fig. 3. Determining factors of the proportion of class C in the hospital. (A) Relationship between the proportion of class C cases and the number of PCIs.

Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome Jonas Faxén, Hong Xu,

Nat. Rev. Cardiol. doi: /nrcardio

Comparison of prescription rates and clinical outcomes in acute coronary syndrome patients who underwent percutaneous coronary intervention using different.

Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease Tetsuro Tsujimoto, Hiroshi Kajio

Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery P.-G. Chassot, A. Delabays, D.R. Spahn

Volume 63, Issue 1, Pages (July 2015)

The Case for Routine CYP2C19 ( Plavix® ) Genetic Testing

Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation.

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.

Any, acute and subacute stent thrombosis with bivalirudin versus unfractionated heparin (UFH) in predominantly ST segment elevation myocardial infarction.

Cardiac Arrest Care Presented By: Mr. Jitendra Singh Coordinator

MRRs and EMRRs for women with ACS

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 1: Non-ST–Segment.

Major bleeding with bivalirudin versus unfractionated heparin (UFH) in predominantly non-ST segment elevation acute coronary syndrome (NSTE-ACS) studies;

Use of evidence-based cardiac medications before, during and after hospitalisation for the index event in (A) overall ACS population and (B) patients with.

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Cardiovascular Epidemiology and Epidemiological Modelling

Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.

Study flow chart and diagnosis at discharge from ED

Presentation transcript:

Volume 81, Issue 10, Pages 1219-1276 (October 2010) European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary Jerry P. Nolan, Jasmeet Soar, David A. Zideman, Dominique Biarent, Leo L. Bossaert, Charles Deakin, Rudolph W. Koster, Jonathan Wyllie, Bernd Böttiger Resuscitation Volume 81, Issue 10, Pages 1219-1276 (October 2010) DOI: 10.1016/j.resuscitation.2010.08.021 Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.1 Chain of Survival. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.2 Basic life support algorithm. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.3 Adult foreign-body airway obstruction (choking) sequence. © 2010 ERC. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.4 AED algorithm. © 2010 ERC. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.5 Algorithm for the initial management of in-hospital cardiac arrest. © 2010 ERC. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.6 ALS cardiac arrest algorithm. © 2010 ERC. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.7 Tachycardia algorithm. © 2010 ERC. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.8 Bradycardia algorithm. © 2010 ERC. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.9 Definitions of acute coronary syndromes (ACS); STEMI, ST elevation myocardial infarction; NSTEMI, non-ST elevation myocardial infarction; UAP, unstable angina pectoris. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.10 Treatment algorithm for acute coronary syndromes; BP, blood pressure; PCI, percutaneous coronary intervention; UFH, unfractionated heparin. *Prasugrel, 60mg loading dose, may be chosen as an alternative to clopidogrel in patients with STEMI and planned PPCI provided there is no history of stroke or transient ischaemic attack. At the time of writing, ticagrelor has not yet been approved as an alternative to clopidogrel. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.11 Paediatric basic life support algorithm for those with a duty to respond. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.12 Paediatric foreign body airway obstruction algorithm. © 2010 ERC. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.13 Paediatric advanced life support algorithm. © 2010 ERC. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions

Fig. 1.14 Newborn life support algorithm. © 2010 ERC. Resuscitation 2010 81, 1219-1276DOI: (10.1016/j.resuscitation.2010.08.021) Copyright © 2010 European Resuscitation Council Terms and Conditions